Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
Loss of T790M mutation is associated with early progression to osimertinib in Chinese patients with advanced NSCLC who are harboring EGFR T790MSha Zhao, Xuefei Li, Chao Zhao, et al.International Journal of Cancer|February 21, 2019
EGFR-targeted therapy alters the tumor microenvironment in EGFR-driven lung tumors: Implications for combination therapiesYijun Jia, Xuefei Li, Tao Jiang, et al.Cancer|March 28, 2017
Clinical features of Bim deletion polymorphism and its relation with crizotinib primary resistance in Chinese patients with ALK/ROS1 fusion-positive non-small cell lung cancerLimin Zhang, Tao Jiang, Xuefei Li, et al.Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|January 23, 2018
Uncommon EGFR mutations in a cohort of Chinese NSCLC patients and outcomes of first-line EGFR-TKIs and platinum-based chemotherapyJinpeng Shi, Hui Yang, Tao Jiang, et al.Translational Lung Cancer Research|December 3, 2021
The safety and efficacy of immunotherapy with anti-programmed cell death 1 monoclonal antibody for lung cancer complicated with Mycobacterium tuberculosis infectionJinpeng Shi, Jiayu Li, Qi Wang, et al.Translational Lung Cancer Research|March 10, 2023
Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer harboring BRAF mutationsHaowei Wang, Lei Cheng, Chao Zhao, et al.Journal of Hematology & Oncology|July 14, 2019
Genomic landscape and its correlations with tumor mutational burden, PD-L1 expression, and immune cells infiltration in Chinese lung squamous cell carcinomaTao Jiang, Jinpeng Shi, Zhengwei Dong, et al.Journal of Cellular and Molecular Medicine|January 3, 2020
Exosomes transmit T790M mutation-induced resistance in EGFR-mutant NSCLC by activating PI3K/AKT signalling pathwayXiaozhen Liu, Tao Jiang, Xuefei Li, et al.Oncology Letters|November 23, 2017
Characterization of distinct types of KRAS mutation and its impact on first-line platinum-based chemotherapy in Chinese patients with advanced non-small cell lung cancerYijun Jia, Tao Jiang, Xuefei Li, et al.Lung Cancer (Amsterdam, Netherlands)|January 2, 2018
Characterization of never-smoking and its association with clinical outcomes in Chinese patients with small-cell lung cancerXiaozhen Liu, Tao Jiang, Wei Li, et al.Pageof 4